Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9252)	6/5/1998 7:48:00 PM
From: g.w. barnard	Respond to of 23519

v, i should be used to being kicked and beaten when down (that is usually the way i make most of my money), but this is extremely frustrating to see so much useless verbage recieve the intended effect. it has presented an opportunity (one which is overextended in my opinion). that said leland needs to be very aggressive in resolving these allegations of efficacy as well as a few others as i have pointed out in past posting. i am still concerned over this qtr's earnings and continue to hone in on the numbers (so many varables) but i believe potential to lose more than the -15 cents first call has. again i have it btw 35 and 45 cents. i will be listening for any news on revenues, scripts, overheads, rampup, margins, capital requirements and yes certain balance sheet items, recievables in particular (although this is not the purpose of the interview). hope he is successful. gw

To: VLAD who wrote (9252)	6/5/1998 8:28:00 PM
From: Zebra 365	Read Replies (1) \| Respond to of 23519

NostraZebra predicts press releases months in advance... The first two releases are real..... RENO, Nev.--(BW HealthWire)--March 4, 1998--Harvard Scientific Corp., (OTC BB:HVSF) a Nevada corporation, announced Wednesday that results from an ongoing stability study for its patented lyophilized liposomal Prostaglandin E-1 ("LLPGE1") has proven that it remains stable at room temperature for at least 9-months. LAKE MARY, Fla.--(BUSINESS WIRE)--June 5, 1998--Harvard Scientific Corp., (OTC Bul Bd: HVSF) a Nevada corporation, announced today that results from an ongoing stability study for its patented lyophilized liposomal Prostaglandin E-1 (''LLPGE1'') has proven that it remains stable at room temperature for at least 12-months without any degradation of the active drug agent. The Company cites this ongoing study as further proof that its product will become the treatment of choice by physicians and their sexual dysfunction patients. THE PREDICTION OF NOSTRAZEBRA.......... LAKE MARY, Fla.--(BUSINESS WIRE)--September 5, 1998--Harvard Scientific Corp., (OTC Bul Bd: HVSF) a Nevada corporation, announced today that results from an ongoing stability study for its patented lyophilized liposomal Prostaglandin E-1 (''LLPGE1'') has proven that it remains stable at room temperature for at least 15-months without any degradation of the active drug agent. The Company cites this ongoing study as further proof that its product will become the treatment of choice by physicians and their sexual dysfunction patients. However it is starting to smell a bit like a junior high locker room around here. They don't call us Waite and See for nothing. <gg> This will be the perfect drug for the guy who can't get any for over a year and doesn't own a refrigerator. Hmm, could there be a connection? I've got it, HVSF has the first impotence treatment directed to the "homeless market." Zebra